Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012227429> ?p ?o ?g. }
- W3012227429 endingPage "488" @default.
- W3012227429 startingPage "477" @default.
- W3012227429 abstract "Introduction: The management of hyperphosphatemia in patients with chronic kidney disease (CKD) is complicated, requiring a multidisciplinary approach that includes dietary phosphate restriction, dialysis, and phosphate binders.Areas covered: We describe key players involved in regulating inorganic phosphate homeostasis and their differential role in healthy people and different stages of CKD. The contribution of paracellular and transcellular intestinal absorptive mechanisms are also examined. Finally, we illuminate recent therapeutic approaches for hyperphosphatemia in CKD. We searched PubMed/Medline (up to November 2019) using the following terms: chronic kidney disease, dialysis, diet, hyperphosphatemia, NaPi2b, nicotinamide, phosphate binder, secondary hyperparathyroidism, tenapanor and vascular calcification.Expert opinion: The precise mechanisms regulating intestinal phosphate absorption in humans is not completely understood. However, it is now established that this process involves two independent pathways: a) active transport (i.e. transcellular route, via specific ion transporters) and inactive transport (i.e. paracellular route across tight junctions). Dietary phosphate restriction and phosphate-binder use can lead to an undesirable maladaptive increase in phosphate uptake and promote active phosphate transport by increased expression of the gastrointestinal sodium-dependent phosphate transporter, NaPi2b. Nicotinamide may overcome these limitations through the inhibition of NaPi2b, by improved efficacy and reduced phosphate binder use and better compliance." @default.
- W3012227429 created "2020-03-23" @default.
- W3012227429 creator A5008053180 @default.
- W3012227429 creator A5021707048 @default.
- W3012227429 creator A5046643853 @default.
- W3012227429 date "2020-03-19" @default.
- W3012227429 modified "2023-10-01" @default.
- W3012227429 title "An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations" @default.
- W3012227429 cites W1608625663 @default.
- W3012227429 cites W1833121085 @default.
- W3012227429 cites W1963541108 @default.
- W3012227429 cites W1973638806 @default.
- W3012227429 cites W1989169668 @default.
- W3012227429 cites W1993099421 @default.
- W3012227429 cites W1999751581 @default.
- W3012227429 cites W2000967798 @default.
- W3012227429 cites W2003607999 @default.
- W3012227429 cites W2004494117 @default.
- W3012227429 cites W2005365992 @default.
- W3012227429 cites W2008282188 @default.
- W3012227429 cites W2009081188 @default.
- W3012227429 cites W2011005615 @default.
- W3012227429 cites W2013429907 @default.
- W3012227429 cites W2015668150 @default.
- W3012227429 cites W2015729033 @default.
- W3012227429 cites W2017688161 @default.
- W3012227429 cites W2018081819 @default.
- W3012227429 cites W2020329972 @default.
- W3012227429 cites W2021720463 @default.
- W3012227429 cites W2023566506 @default.
- W3012227429 cites W2023883454 @default.
- W3012227429 cites W2025589168 @default.
- W3012227429 cites W2027479037 @default.
- W3012227429 cites W2028302756 @default.
- W3012227429 cites W2028962633 @default.
- W3012227429 cites W2030174339 @default.
- W3012227429 cites W2031311109 @default.
- W3012227429 cites W2031941775 @default.
- W3012227429 cites W2033826233 @default.
- W3012227429 cites W2039686521 @default.
- W3012227429 cites W2042428144 @default.
- W3012227429 cites W2059360654 @default.
- W3012227429 cites W2059629870 @default.
- W3012227429 cites W2061845586 @default.
- W3012227429 cites W2062435336 @default.
- W3012227429 cites W2068935764 @default.
- W3012227429 cites W2072718197 @default.
- W3012227429 cites W2076466637 @default.
- W3012227429 cites W2078730571 @default.
- W3012227429 cites W2079776396 @default.
- W3012227429 cites W2079922348 @default.
- W3012227429 cites W2082951676 @default.
- W3012227429 cites W2093778549 @default.
- W3012227429 cites W2098901188 @default.
- W3012227429 cites W2100644178 @default.
- W3012227429 cites W2102734552 @default.
- W3012227429 cites W2103418075 @default.
- W3012227429 cites W2114669693 @default.
- W3012227429 cites W2115276988 @default.
- W3012227429 cites W2115431937 @default.
- W3012227429 cites W2118432033 @default.
- W3012227429 cites W2127674924 @default.
- W3012227429 cites W2127828880 @default.
- W3012227429 cites W2130381721 @default.
- W3012227429 cites W2131952235 @default.
- W3012227429 cites W2132700529 @default.
- W3012227429 cites W2135786480 @default.
- W3012227429 cites W2136628690 @default.
- W3012227429 cites W2140169648 @default.
- W3012227429 cites W2142343526 @default.
- W3012227429 cites W2143657892 @default.
- W3012227429 cites W2145632027 @default.
- W3012227429 cites W2146507287 @default.
- W3012227429 cites W2146648131 @default.
- W3012227429 cites W2149030597 @default.
- W3012227429 cites W2152330606 @default.
- W3012227429 cites W2153237907 @default.
- W3012227429 cites W2158561625 @default.
- W3012227429 cites W2159814168 @default.
- W3012227429 cites W2164600947 @default.
- W3012227429 cites W2166159490 @default.
- W3012227429 cites W2166377418 @default.
- W3012227429 cites W2168524187 @default.
- W3012227429 cites W2170654514 @default.
- W3012227429 cites W2216144092 @default.
- W3012227429 cites W2281172691 @default.
- W3012227429 cites W2312101298 @default.
- W3012227429 cites W2466325962 @default.
- W3012227429 cites W2538263534 @default.
- W3012227429 cites W2551772736 @default.
- W3012227429 cites W2560519247 @default.
- W3012227429 cites W2572372393 @default.
- W3012227429 cites W2584796864 @default.
- W3012227429 cites W2700576091 @default.
- W3012227429 cites W2743203236 @default.
- W3012227429 cites W2753795154 @default.
- W3012227429 cites W2772719976 @default.
- W3012227429 cites W2789335667 @default.